Objects
2517
Multi-source
1837
Risk Δ
657
Field flags
1069
Sentry+ESA
1812
Objects
IP / Palermo / Torino disagree past threshold.
| Designation | Coverage | Approach | Distance | v_rel | Risk | Comparison |
|---|---|---|---|---|---|---|
| 2025 CL3cross-match | CADSNTESA 3/3 | 2026-Sep-01 04:24 | 0.024483 au · 9.53 LDdist. ≠ | 13.54 km/s | T0PS -4.07 | risk 2 |
| 2026 OA3cross-match | CADSNTESA 3/3 | 2026-Jul-27 04:22 | 0.012629 au · 4.92 LD | 5.22 km/s | T0PS -5.56 | risk 2 |
| 2019 GP21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.77 | risk 2 |
| 2018 WA1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.08 | risk 2 |
| 2025 XQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.21 | risk 2 |
| 2025 YU11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.96 | risk 2 |
| 2026 ABcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.13 | risk 2 |
| 2026 BD6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.76 | risk 2 |
| 2008 PK9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.74 | risk 2 |
| 2022 UQ40cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.04 | risk 2 |
| 2019 QScross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.34 | risk 2 |
| 2020 PCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.21 | risk 2 |
| 2017 JB2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.92 | risk 2 |
| 2002 AN129cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.42 | risk 2 |
| 2017 YD1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.44 | risk 2 |
| 2022 YCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.34 | risk 2 |
| 2014 CR13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.62 | risk 2 |
| 2020 SX6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.07 | risk 2 |
| 2010 UBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.51 | risk 2 |
| 2009 XR1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.01 | risk 2 |
| 2020 DWcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.26 | risk 2 |
| 2009 VT1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.51 | risk 2 |
| 2022 DO2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.65 | risk 2 |
| 2017 UQ6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.88 | risk 2 |
| 2022 GEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.09 | risk 2 |
| 2022 EDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.43 | risk 2 |
| 2019 AU6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.89 | risk 2 |
| 2018 RB2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.92 | risk 2 |
| 2020 GB1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.36 | risk 2 |
| 2011 AM37cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.15 | risk 2 |
| 2011 BL45cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.32 | risk 2 |
| 2002 GM5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.84 | risk 2 |
| 2021 RM10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.98 | risk 2 |
| 2021 GZ7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.99 | risk 2 |
| 2021 JY3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.72 | risk 2 |
| 2018 VS6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.37 | risk 2 |
| 2009 TBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.97 | risk 2 |
| 2022 SY24cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.69 | risk 2 |
| 2008 CJcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.50 | risk 2 |
| 2008 UC202cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.99 | risk 2 |
| 2021 EAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.45 | risk 2 |
| 2021 FUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.77 | risk 2 |
| 2020 KJ4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.35 | risk 2 |
| 2026 EL2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.02 | risk 2 |
| 2012 VE77cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.08 | risk 2 |
| 2014 WU200cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.46 | risk 2 |
| 2009 TD17cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.55 | risk 2 |
| 2014 HY198cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.51 | risk 2 |
| 2009 QRcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.77 | risk 2 |
| 2009 EJ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.71 | risk 2 |
| 2019 VE4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.11 | risk 2 |
| 2020 BHcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.29 | risk 2 |
| 2009 BR5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.08 | risk 2 |
| 2017 FX158cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.76 | risk 2 |
| 2021 PA211cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.29 | risk 2 |
| 2021 UP120cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.42 | risk 2 |
| 2005 TH50cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.79 | risk 2 |
| 2006 CM10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.26 | risk 2 |
| 2016 LG10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.15 | risk 2 |
| 2019 KY3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.29 | risk 2 |
| 2017 YO3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.72 | risk 2 |
| 2018 GEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.49 | risk 2 |
| 2020 FDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.96 | risk 2 |
| 2010 GH7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.46 | risk 2 |
| 2007 BBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.97 | risk 2 |
| 2018 BP6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.66 | risk 2 |
| 2017 VC14cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.80 | risk 2 |
| 2019 YScross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.09 | risk 2 |
| 2018 SD2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.06 | risk 2 |
| 2021 AB4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.79 | risk 2 |
| 2008 CT1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.97 | risk 2 |
| 2011 EBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.45 | risk 2 |
| 2013 QM48cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.92 | risk 2 |
| 2021 HY9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.03 | risk 2 |
| 2021 JB6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.78 | risk 2 |
| 2022 RD2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.20 | risk 2 |
| 2020 GZ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.57 | risk 2 |
| 2020 DN3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.53 | risk 2 |
| 2005 TAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.08 | risk 2 |
| 2018 BP3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.36 | risk 2 |
| 2019 MT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.21 | risk 2 |
| 2014 QN266cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.63 | risk 2 |
| 2006 UQ216cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.83 | risk 2 |
| 2019 BX1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.23 | risk 2 |
| 1993 HP1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.40 | risk 2 |
| 2018 NJcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.78 | risk 2 |
| 2008 JL24cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.69 | risk 2 |
| 2005 AU3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.37 | risk 2 |
| 2008 CB6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.30 | risk 2 |
| 2025 DB15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.56 | risk 2 |
| 2025 FZ6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.63 | risk 2 |
| 2023 PZcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.38 | risk 2 |
| 2014 HD198cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.96 | risk 2 |
| 2020 GA3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.40 | risk 2 |
| 2017 OE7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.67 | risk 2 |
| 2020 QCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.74 | risk 2 |
| 2019 YA3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.54 | risk 2 |
| 2011 UD21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.97 | risk 2 |
| 2026 FL12cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.26 | risk 2 |
| 2026 CCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.83 | risk 2 |
| 2011 BG10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.33 | risk 2 |
| 2020 BY4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.35 | risk 2 |
| 2010 VQ98cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.61 | risk 2 |
| 2017 UJ43cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.68 | risk 2 |
| 2016 UR36cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.97 | risk 2 |
| 2007 HB15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.67 | risk 2 |
| 2003 UM3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.60 | risk 2 |
| 2020 TS1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.79 | risk 2 |
| 2019 KLcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.29 | risk 2 |
| 2020 HE7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.09 | risk 2 |
| 2012 TU231cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.01 | risk 2 |
| 2014 WA366cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.76 | risk 2 |
| 2022 UW15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.92 | risk 2 |
| 2022 YK3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.57 | risk 2 |
| 2024 PJ3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.16 | risk 2 |
| 2013 FU13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.46 | risk 2 |
| 2018 CA15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.61 | risk 2 |
| 2018 VC7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.54 | risk 2 |
| 2021 PM1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.86 | risk 2 |
| 2016 KOcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.99 | risk 2 |
| 2024 CM5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.94 | risk 2 |
| 2016 XL23cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.37 | risk 2 |
| 2017 AA21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.30 | risk 2 |
| 2017 DP109cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.59 | risk 2 |
| 2020 PW2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.55 | risk 2 |
| 2021 TN14cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.17 | risk 2 |
| 2018 JL1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.48 | risk 2 |
| 2020 CK2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.82 | risk 2 |
| 2022 YR4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.77 | risk 2 |
| 2020 CO2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.15 | risk 2 |
| 2020 HV5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.25 | risk 2 |
| 2002 UV36cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.18 | risk 2 |
| 2007 VE8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.85 | risk 2 |
| 2016 EP84cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.08 | risk 2 |
| 2020 RJ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.03 | risk 2 |
| 2019 NF7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.61 | risk 2 |
| 2014 KS76cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.31 | risk 2 |
| 2013 NJ4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.56 | risk 2 |
| 2016 AB166cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.61 | risk 2 |
| 2019 LA2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.37 | risk 2 |
| 2013 HN158cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.66 | risk 2 |
| 2013 RZ53cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.65 | risk 2 |
| 2001 BA16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.11 | risk 2 |
| 2012 TP20cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.07 | risk 2 |
| 2019 SX8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.40 | risk 2 |
| 2019 XVcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.43 | risk 2 |
| 2022 CL7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.12 | risk 2 |
| 2018 HW1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.59 | risk 2 |
| 2019 GK3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.46 | risk 2 |
| 2016 JAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.99 | risk 2 |
| 2022 EF3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.35 | risk 2 |
| 2016 EV84cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.69 | risk 2 |
| 2025 QG16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.28 | risk 2 |
| 2026 MRcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.01 | risk 2 |
| 2008 CE22cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.40 | risk 2 |
| 2021 LK6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.46 | risk 2 |
| 2021 LL15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.20 | risk 2 |
| 2019 SG1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.12 | risk 2 |
| 2020 CQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.22 | risk 2 |
| 2020 BY11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.10 | risk 2 |
| 2020 QR5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.36 | risk 2 |
| 2019 JX1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.61 | risk 2 |
| 2009 SH2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.13 | risk 2 |
| 2018 LMcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.25 | risk 2 |
| 2024 VR4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.43 | risk 2 |
| 2025 FU9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.74 | risk 2 |
| 2011 AK37cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.19 | risk 2 |
| 2021 NBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.92 | risk 2 |
| 2020 TY4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.83 | risk 2 |
| 2018 LE1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.31 | risk 2 |
| 2012 UEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.04 | risk 2 |
| 2018 JDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.42 | risk 2 |
| 2020 TD8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.90 | risk 2 |
| 2021 SF1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.02 | risk 2 |
| 2007 FT3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.06 | risk 2 |
| 2021 EL3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.42 | risk 2 |
| 2017 KC36cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.74 | risk 2 |
| 2020 AO1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.71 | risk 2 |
| 2019 QDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.86 | risk 2 |
| 2021 GM1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.71 | risk 2 |
| 2020 GZ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.88 | risk 2 |
| 2004 GE2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.02 | risk 2 |
| 2011 DU9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.23 | risk 2 |
| 2017 BK30cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.20 | risk 2 |
| 2021 HE41cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.54 | risk 2 |
| 2016 TMcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.84 | risk 2 |
| 2004 XB45cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.18 | risk 2 |
| 2012 XB112cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.77 | risk 2 |
| 2019 WEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.80 | risk 2 |
| 2015 XR169cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.15 | risk 2 |
| 2018 MC7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.96 | risk 2 |
| 2018 EL4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.98 | risk 2 |
| 2019 CM5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.68 | risk 2 |
| 2018 WA3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.22 | risk 2 |
| 2016 AF2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.15 | risk 2 |
| 2018 RJ3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.37 | risk 2 |
| 2011 WQ4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.27 | risk 2 |
| 2014 WAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.05 | risk 2 |
| 2013 GW38cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.25 | risk 2 |
| 2019 SM8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.28 | risk 2 |
| 2007 YMcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.99 | risk 2 |
| 2021 OE1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.80 | risk 2 |
| 2003 WT153cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.19 | risk 2 |
| 2019 TAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.32 | risk 2 |
| 2016 HF3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.06 | risk 2 |
| 2019 LW4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.25 | risk 2 |
| 2015 QS8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.40 | risk 2 |
| 2010 NHcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.74 | risk 2 |
| 2020 FA1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.85 | risk 2 |
| 2021 UL7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.18 | risk 2 |
| 2022 GBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.24 | risk 2 |
| 2017 UL5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.42 | risk 2 |
| 2021 BR2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.53 | risk 2 |
| 2021 CC7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.10 | risk 2 |
| 2020 YK3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.24 | risk 2 |
| 2021 CH37cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.75 | risk 2 |
| 2020 WT4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.92 | risk 2 |
| 2020 VB3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.48 | risk 2 |
| 2020 VN1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.66 | risk 2 |
| 2020 VK6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.32 | risk 2 |
| 2021 CD8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.16 | risk 2 |
| 2020 YNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.83 | risk 2 |
| 2020 YS2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.06 | risk 2 |
| 2021 EW1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.42 | risk 2 |
| 2021 RL14cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.84 | risk 2 |
| 2021 FO1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.40 | risk 2 |
| 2021 CF1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.00 | risk 2 |
| 2020 YG2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.08 | risk 2 |
| 2022 JK2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.22 | risk 2 |
| 2021 KT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.87 | risk 2 |
| 2021 GC8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.24 | risk 2 |
| 2022 UE61cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.80 | risk 2 |
| 2021 UW1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.45 | risk 2 |
| 2021 VM22cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.84 | risk 2 |
| 2021 VP8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.14 | risk 2 |
| 2021 WR4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.01 | risk 2 |
| 2021 VY7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.35 | risk 2 |
| 2021 XC2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.70 | risk 2 |
| 2021 VT4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.21 | risk 2 |
| 2021 WC1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.27 | risk 2 |
| 2021 XF1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.51 | risk 2 |
| 2022 KF6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.21 | risk 2 |
| 2019 LU1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.20 | risk 2 |
| 2022 WT6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.39 | risk 2 |
| 2022 SJ9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.66 | risk 2 |
| 2022 SJ28cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.78 | risk 2 |
| 2022 OKcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.70 | risk 2 |
| 2022 SO11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.41 | risk 2 |
| 2022 PX1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.10 | risk 2 |
| 2022 QOcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.93 | risk 2 |
| 2022 SL4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.44 | risk 2 |
| 2022 SW24cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.78 | risk 2 |
| 2016 THcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.31 | risk 2 |
| 2022 BM3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.78 | risk 2 |
| 2018 BDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.91 | risk 2 |
| 2019 NP5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.74 | risk 2 |
| 2020 KUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.78 | risk 2 |
| 2021 TS10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.46 | risk 2 |
| 2020 UYcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.88 | risk 2 |
| 2021 LD6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.25 | risk 2 |
| 2022 AB4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.36 | risk 2 |
| 2021 PL132cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.52 | risk 2 |
| 2021 XK3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.81 | risk 2 |
| 2022 KM4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.33 | risk 2 |
| 2022 KO3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.33 | risk 2 |
| 2021 XD6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.78 | risk 2 |
| 2021 UTcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.24 | risk 2 |
| 2021 VZ22cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.16 | risk 2 |
| 2021 WL2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.94 | risk 2 |
| 2021 WV1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.40 | risk 2 |
| 2022 BA7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.09 | risk 2 |
| 2022 BFcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.49 | risk 2 |
| 2021 XZ5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.51 | risk 2 |
| 2021 WZ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.73 | risk 2 |
| 2021 RG12cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.65 | risk 2 |
| 2023 DXcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.50 | risk 2 |
| 2023 CW2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.87 | risk 2 |
| 2023 OR1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.95 | risk 2 |
| 2023 ET2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.49 | risk 2 |
| 2015 EG7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.45 | risk 2 |
| 2023 OD1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.14 | risk 2 |
| 2023 AN6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.87 | risk 2 |
| 2023 JKcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.05 | risk 2 |
| 2023 EScross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.15 | risk 2 |
| 2023 KU2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.61 | risk 2 |
| 2014 SH224cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.39 | risk 2 |
| 2023 JE5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.52 | risk 2 |
| 2020 HL1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.86 | risk 2 |
| 2023 KT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.73 | risk 2 |
| 2023 KTcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.63 | risk 2 |
| 2024 MDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.30 | risk 2 |
| 2025 VW3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.55 | risk 2 |
| 2023 SN8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.93 | risk 2 |
| 2023 XQ16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.95 | risk 2 |
| 2023 VD3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.90 | risk 2 |
| 2022 QE265cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.08 | risk 2 |
| 2023 FZ48cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.71 | risk 2 |
| 2023 VE1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.37 | risk 2 |
| 2024 EJ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.19 | risk 2 |
| 2024 BQ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.24 | risk 2 |
| 2024 BP4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.65 | risk 2 |
| 2020 FZ46cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.47 | risk 2 |
| 2024 JNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.74 | risk 2 |
| 2023 SD3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.16 | risk 2 |
| 2024 EJ4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.20 | risk 2 |
| 2024 HCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.50 | risk 2 |
| 2024 TK13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.35 | risk 2 |
| 2024 MS1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.27 | risk 2 |
| 2024 WT3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.97 | risk 2 |
| 2018 CMcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.20 | risk 2 |
| 2021 FE2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.58 | risk 2 |
| 2024 QQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.56 | risk 2 |
| 2024 PR5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.32 | risk 2 |
| 2024 TB7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.74 | risk 2 |
| 2024 RQ5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.88 | risk 2 |
| 2024 RA16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.56 | risk 2 |
| 2024 RN2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.55 | risk 2 |
| 2024 RB3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.38 | risk 2 |
| 2024 RZ21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.77 | risk 2 |
| 2024 RC16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.26 | risk 2 |
| 2024 RE16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.68 | risk 2 |
| 2024 RF10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.74 | risk 2 |
| 2024 RS16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.82 | risk 2 |
| 2022 MK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.91 | risk 2 |
| 2024 TTcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.71 | risk 2 |
| 1995 UBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.35 | risk 2 |
| 2024 UN2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.15 | risk 2 |
| 2024 UN8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.06 | risk 2 |
| 2024 VK3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.12 | risk 2 |
| 2024 UD11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.78 | risk 2 |
| 2020 ME63cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.34 | risk 2 |
| 2021 NF90cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.13 | risk 2 |
| 2024 XCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.37 | risk 2 |
| 2024 XD11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.39 | risk 2 |
| 2024 YN9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.78 | risk 2 |
| 2025 BNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.52 | risk 2 |
| 2025 BP4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.12 | risk 2 |
| 2025 BS4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.26 | risk 2 |
| 2025 CMcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.91 | risk 2 |
| 2025 DE1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.46 | risk 2 |
| 2016 EU84cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.34 | risk 2 |
| 2025 NM1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.98 | risk 2 |
| 2025 HUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.53 | risk 2 |
| 2025 HCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.54 | risk 2 |
| 2025 FM10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.19 | risk 2 |
| 2025 OE4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.55 | risk 2 |
| 2025 KK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.75 | risk 2 |
| 2025 KF2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.15 | risk 2 |
| 2025 KE4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.61 | risk 2 |
| 2025 SH6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.80 | risk 2 |
| 2025 MAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.84 | risk 2 |
| 2025 MCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.83 | risk 2 |
| 2025 MR89cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.76 | risk 2 |
| 2025 SB9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.21 | risk 2 |
| 2025 UNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.23 | risk 2 |
| 2025 UY7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.19 | risk 2 |
| 2025 QA5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.70 | risk 2 |
| 2025 MV89cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.53 | risk 2 |
| 2026 HUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.11 | risk 2 |
| 2025 NCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.76 | risk 2 |
| 2025 OBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.10 | risk 2 |
| 2025 PQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.73 | risk 2 |
| 2025 SB21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.40 | risk 2 |
| 2025 RP3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.25 | risk 2 |
| 2025 SS7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.68 | risk 2 |
| 2025 TS14cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.71 | risk 2 |
| 2025 UJ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.91 | risk 2 |
| 2025 UV1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.23 | risk 2 |
| 2025 VM5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.38 | risk 2 |
| 2025 WD10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.46 | risk 2 |
| 2025 WK16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.70 | risk 2 |
| 2025 XNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.04 | risk 2 |
| 2025 XMcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.33 | risk 2 |
| 2025 XF2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.75 | risk 2 |
| 2025 XL6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.09 | risk 2 |
| 2026 AG5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.94 | risk 2 |
| 2025 YS1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.33 | risk 2 |
| 2026 AW1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.90 | risk 2 |
| 2025 LKcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.65 | risk 2 |
| 2026 BS7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.93 | risk 2 |
| 2026 BZ5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.88 | risk 2 |
| 2026 MT1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.25 | risk 2 |
| 2026 LK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.74 | risk 2 |
| 2026 LS1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.73 | risk 2 |
| 2026 DL8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.86 | risk 2 |
| 2026 DP11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.97 | risk 2 |
| 2026 EQ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.86 | risk 2 |
| 2026 LWcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.46 | risk 2 |
| 2026 EL3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.15 | risk 2 |
| 2026 EO3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.16 | risk 2 |
| 2026 GQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.99 | risk 2 |
| 2026 GYcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.78 | risk 2 |
| 2026 GPcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.99 | risk 2 |
| 2026 HK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.38 | risk 2 |
| 2026 HM6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.62 | risk 2 |
| 2026 HE1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.15 | risk 2 |
| 2026 HR5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.41 | risk 2 |
| 2026 JW2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.77 | risk 2 |
| 2026 KO1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.72 | risk 2 |
| 2026 ODcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.54 | risk 2 |
| 2026 OGcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.87 | risk 2 |
| 2025 UZ7cross-match | CADSNTESA 2/3 | 2027-02-22 | 0.036326 au · 14.14 LD | 7.80 km/s | T0PS -9.11 | risk 2 |
| 2022 DO3cross-match | CADSNTESA 2/3 | 2027-02-23 | 0.041324 au · 16.09 LD | 14.40 km/s | T0PS -6.06 | risk 2 |
| 2021 TG14cross-match | CADSNTESA 2/3 | 2027-04-16 | 0.033682 au · 13.11 LD | 12.30 km/s | T0PS -7.48 | risk 2 |
| 2023 LCcross-match | CADSNTESA 2/3 | 2027-04-25 | 0.033155 au · 12.91 LD | 3.40 km/s | T0PS -9.35 | risk 2 |
| 2026 JB2cross-match | CADSNTESA 2/3 | 2027-05-17 | 0.046702 au · 18.18 LD | 14.30 km/s | T0PS -6.67 | risk 2 |
| 2007 EKcross-match | CADSNTESA 3/3 | 2026-Aug-30 17:37 | 0.028000 au · 10.90 LDdist. ≠ | 9.14 km/s | T0PS -9.70 | risk 1 |
| 2009 DVcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.24 | risk 1 |
| 2005 CM7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.12 | risk 1 |
| 2025 YQ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.66 | risk 1 |
| 2016 TQ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.79 | risk 1 |
| 2010 XUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.56 | risk 1 |
| 2019 UN13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.76 | risk 1 |
| 2024 XC17cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.01 | risk 1 |
| 2013 TX68cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.95 | risk 1 |
| 2017 QJ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.35 | risk 1 |
| 2012 XL134cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.62 | risk 1 |
| 2018 LD1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.90 | risk 1 |
| 2024 GV3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.60 | risk 1 |
| 2005 UA1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.99 | risk 1 |
| 2006 DO62cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.27 | risk 1 |
| 2020 TF6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.17 | risk 1 |
| 2005 TK50cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.70 | risk 1 |
| 2018 FK5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.18 | risk 1 |
| 2019 QE7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.66 | risk 1 |
| 2019 WUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.06 | risk 1 |
| 2011 DE5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.58 | risk 1 |
| 2008 SH148cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.77 | risk 1 |
| 2017 UK52cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.50 | risk 1 |
| 2017 WE28cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.39 | risk 1 |
| 2022 OR1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.81 | risk 1 |
| 2021 BL2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.08 | risk 1 |
| 2019 HR2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.75 | risk 1 |
| 2012 TVcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.32 | risk 1 |
| 2018 BCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.67 | risk 1 |
| 2019 FB1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.17 | risk 1 |
| 2004 OD4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.90 | risk 1 |
| 2018 LT5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.65 | risk 1 |
| 1994 GKcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.18 | risk 1 |
| 2007 VF189cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.22 | risk 1 |
| 2016 NP56cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.45 | risk 1 |
| 2019 HS3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.33 | risk 1 |
| 2017 WE30cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.00 | risk 1 |
| 2012 CS46cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.00 | risk 1 |
| 2024 GO1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.45 | risk 1 |
| 2020 UCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.35 | risk 1 |
| 2005 EL70cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.83 | risk 1 |
| 2018 JNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.35 | risk 1 |
| 2016 DBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.16 | risk 1 |
| 2022 BD1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.90 | risk 1 |
| 2003 YS70cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.85 | risk 1 |
| 2008 EA9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.80 | risk 1 |
| 2019 SJcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.76 | risk 1 |
| 1995 CScross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.07 | risk 1 |
| 2020 WA1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.34 | risk 1 |
| 2022 AT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.71 | risk 1 |
| 2007 VC3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.82 | risk 1 |
| 2004 FM4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.60 | risk 1 |
| 2018 EV3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.58 | risk 1 |
| 2020 XK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.89 | risk 1 |
| 2016 EO28cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.63 | risk 1 |
| 2016 FA14cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.01 | risk 1 |
| 2019 FEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.12 | risk 1 |
| 2006 BO7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.03 | risk 1 |
| 2015 FH37cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.92 | risk 1 |
| 2016 FC1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.52 | risk 1 |
| 2022 HO2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.63 | risk 1 |
| 2005 TM173cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.71 | risk 1 |
| 2013 UJ5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -11.21 | risk 1 |
| 2011 CW46cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.35 | risk 1 |
| 2012 AQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -11.06 | risk 1 |
| 2012 VJ38cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.18 | risk 1 |
| 2002 XV90cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.21 | risk 1 |
| 2006 EH1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.46 | risk 1 |
| 2018 WH1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.07 | risk 1 |
| 2018 WJcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.99 | risk 1 |
| 2014 OP2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.68 | risk 1 |
| 2019 SO6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.53 | risk 1 |
| 2019 FT1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.77 | risk 1 |
| 2007 PR25cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.18 | risk 1 |
| 2010 UEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.98 | risk 1 |
| 2021 BNcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.91 | risk 1 |
| 2021 GL16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.31 | risk 1 |
| 2019 JH7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.62 | risk 1 |
| 2020 YM1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.75 | risk 1 |
| 2022 WF15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.88 | risk 1 |
| 2022 UV4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.26 | risk 1 |
| 2022 VQcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.88 | risk 1 |
| 2022 WR4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.87 | risk 1 |
| 2023 CC3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.60 | risk 1 |
| 2022 YY5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.99 | risk 1 |
| 2020 QJ5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.63 | risk 1 |
| 2019 YEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.89 | risk 1 |
| 2021 LC3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.91 | risk 1 |
| 2026 ES1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.64 | risk 1 |
| 2014 XE32cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.48 | risk 1 |
| 2020 SY4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.84 | risk 1 |
| 2008 KTcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.87 | risk 1 |
| 2021 AHcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.46 | risk 1 |
| 2017 SA21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.60 | risk 1 |
| 2019 CZ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.26 | risk 1 |
| 2008 TS10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.42 | risk 1 |
| 2007 KE4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.76 | risk 1 |
| 2024 VK2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.57 | risk 1 |
| 2017 YM1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.72 | risk 1 |
| 2015 VK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.82 | risk 1 |
| 2019 BV2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.22 | risk 1 |
| 2019 CJ4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.12 | risk 1 |
| 2020 KU2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.81 | risk 1 |
| 2019 JY2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.49 | risk 1 |
| 2018 GR4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.58 | risk 1 |
| 2022 BU6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.20 | risk 1 |
| 2019 FU1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.81 | risk 1 |
| 2022 GW2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.32 | risk 1 |
| 2026 MHcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.27 | risk 1 |
| 2001 HJ31cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.60 | risk 1 |
| 2019 CY1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.30 | risk 1 |
| 2016 TTcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.06 | risk 1 |
| 2006 SCcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.74 | risk 1 |
| 2021 TJ15cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.60 | risk 1 |
| 2005 CC37cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.98 | risk 1 |
| 2021 HY2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.26 | risk 1 |
| 2021 VW6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.26 | risk 1 |
| 2018 TS6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.65 | risk 1 |
| 2018 FL29cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.74 | risk 1 |
| 2018 PA25cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.44 | risk 1 |
| 2020 VH5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.36 | risk 1 |
| 2020 YA1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.79 | risk 1 |
| 2021 EO2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.77 | risk 1 |
| 2020 RB7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.48 | risk 1 |
| 2015 FN36cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.87 | risk 1 |
| 2004 XO63cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.68 | risk 1 |
| 2005 XA8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.34 | risk 1 |
| 2020 TWcross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.95 | risk 1 |
| 2014 OM207cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.88 | risk 1 |
| 2017 FD3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.58 | risk 1 |
| 2020 VKcross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.72 | risk 1 |
| 2020 VVcross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.81 | risk 1 |
| 2025 HS18cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.57 | risk 1 |
| 2017 YC6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.48 | risk 1 |
| 2020 XF4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.17 | risk 1 |
| 2002 EM7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.76 | risk 1 |
| 2017 KJ32cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.50 | risk 1 |
| 2025 CJ3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.02 | risk 1 |
| 2021 CA6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.87 | risk 1 |
| 2020 KD1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.37 | risk 1 |
| 2017 TT3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.21 | risk 1 |
| 2001 YN2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.42 | risk 1 |
| 2021 CZ7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.29 | risk 1 |
| 2010 QG2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.43 | risk 1 |
| 1997 TC25cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.09 | risk 1 |
| 2020 XA6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.97 | risk 1 |
| 2021 EF3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.14 | risk 1 |
| 2021 TK11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.77 | risk 1 |
| 2021 QY3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.59 | risk 1 |
| 2022 HB2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.97 | risk 1 |
| 2021 TH13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.19 | risk 1 |
| 2021 US1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.24 | risk 1 |
| 2021 WU4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.78 | risk 1 |
| 2021 VA9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.36 | risk 1 |
| 2021 VM1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.53 | risk 1 |
| 2022 KC3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.19 | risk 1 |
| 2022 OK5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.79 | risk 1 |
| 2022 SA11cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.55 | risk 1 |
| 2022 UGcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.75 | risk 1 |
| 2022 VDcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.60 | risk 1 |
| 2018 NWcross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.62 | risk 1 |
| 2019 NK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.90 | risk 1 |
| 2021 TV10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.49 | risk 1 |
| 2021 WUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.74 | risk 1 |
| 2021 WE3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.37 | risk 1 |
| 2017 DG16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.27 | risk 1 |
| 2021 UUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.87 | risk 1 |
| 2021 XV4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.94 | risk 1 |
| 2022 DA3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.38 | risk 1 |
| 2021 XX4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.59 | risk 1 |
| 2021 XZ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.46 | risk 1 |
| 2007 EE126cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.47 | risk 1 |
| 2021 UX1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.06 | risk 1 |
| 2022 WR27cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.14 | risk 1 |
| 2023 EG1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.17 | risk 1 |
| 2022 WS27cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.28 | risk 1 |
| 2023 HT6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.48 | risk 1 |
| 2023 JVcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.93 | risk 1 |
| 2023 RM16cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.57 | risk 1 |
| 2023 NG1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.97 | risk 1 |
| 2025 AC1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.48 | risk 1 |
| 2024 GY5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.15 | risk 1 |
| 2017 UM52cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.35 | risk 1 |
| 2023 SE2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.77 | risk 1 |
| 2023 SR5cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.13 | risk 1 |
| 2023 VK1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.35 | risk 1 |
| 2023 TB2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.06 | risk 1 |
| 2023 TW2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.78 | risk 1 |
| 2023 UBcross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.41 | risk 1 |
| 2023 UEcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.26 | risk 1 |
| 2022 QC265cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.99 | risk 1 |
| 1998 BT13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.99 | risk 1 |
| 2023 XZ13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.45 | risk 1 |
| 2024 AM4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.80 | risk 1 |
| 2010 DG77cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.06 | risk 1 |
| 2025 SUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.65 | risk 1 |
| 2025 UX18cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.70 | risk 1 |
| 2025 VXcross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.79 | risk 1 |
| 2024 FD1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -10.08 | risk 1 |
| 2023 HO36cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.03 | risk 1 |
| 2024 JTcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.28 | risk 1 |
| 2024 GF6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.72 | risk 1 |
| 2024 HL2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.45 | risk 1 |
| 2007 UT3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.66 | risk 1 |
| 2024 QL1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.18 | risk 1 |
| 2024 WU24cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.26 | risk 1 |
| 2024 UScross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.69 | risk 1 |
| 2024 RY10cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.57 | risk 1 |
| 2024 RZ3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.49 | risk 1 |
| 2024 TGcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.32 | risk 1 |
| 2014 HJ198cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.02 | risk 1 |
| 2015 WP2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.32 | risk 1 |
| 2025 CY2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.04 | risk 1 |
| 2024 UG21cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.06 | risk 1 |
| 2024 UD8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.45 | risk 1 |
| 2024 WQ2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.32 | risk 1 |
| 2024 UB1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.22 | risk 1 |
| 2024 WS1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.73 | risk 1 |
| 2024 XS8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.34 | risk 1 |
| 2024 YH7cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.11 | risk 1 |
| 2024 YE9cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.58 | risk 1 |
| 2025 DT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -3.77 | risk 1 |
| 2025 EX1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.48 | risk 1 |
| 2019 DFcross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.60 | risk 1 |
| 2025 DM2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.37 | risk 1 |
| 2025 GScross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.29 | risk 1 |
| 2025 MJ91cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.27 | risk 1 |
| 2026 AC17cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.59 | risk 1 |
| 2025 NO1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.80 | risk 1 |
| 2025 PUcross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.38 | risk 1 |
| 2025 OV20cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.45 | risk 1 |
| 2025 VT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.52 | risk 1 |
| 2025 UC6cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.91 | risk 1 |
| 2025 WR1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -11.34 | risk 1 |
| 2025 WQ8cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.26 | risk 1 |
| 2025 VM3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.19 | risk 1 |
| 2025 XE2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.77 | risk 1 |
| 2025 YX4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.84 | risk 1 |
| 2025 YK4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.49 | risk 1 |
| 2026 AE4cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.41 | risk 1 |
| 2026 DL14cross-match | CADSNTESA 2/3 | — | — | — | T0PS -5.10 | risk 1 |
| 2026 FU3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.40 | risk 1 |
| 2026 FR13cross-match | CADSNTESA 2/3 | — | — | — | T0PS -8.41 | risk 1 |
| 2026 FM3cross-match | CADSNTESA 2/3 | — | — | — | T0PS -6.45 | risk 1 |
| 2026 GN18cross-match | CADSNTESA 2/3 | — | — | — | T0PS -4.37 | risk 1 |
| 2026 GT2cross-match | CADSNTESA 2/3 | — | — | — | T0PS -9.89 | risk 1 |
| 2026 JQ1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.31 | risk 1 |
| 2026 JAcross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.30 | risk 1 |
| 2026 HX1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.20 | risk 1 |
| 2026 OB1cross-match | CADSNTESA 2/3 | — | — | — | T0PS -7.90 | risk 1 |
| 2020 HQ4cross-match | CADSNTESA 2/3 | 2027-03-14 | 0.010787 au · 4.20 LD | 3.30 km/s | T0PS -5.28 | risk 1 |